Back to funds
View filing
B Group, Inc.
Updated 6 days agoManaged by B Group, Inc. • Latest filing Q3 2026
Portfolio value
$162.1M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $135.4M |
| Q1 2026 | $134.9M |
| Q2 2026 | $213M |
| Q3 2026 | $162.1M |
Top holdings
19 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $32.7M | 3.26M | 20.18% | — | |
| 2 | $18.1M | 610.2K | 11.19% | — | |
| 3 | ? N/A PALISADE BIO INC | $15.4M | 11.41M | 9.50% | — |
| 4 | ? N/A NRX PHARMACEUTICALS INC | $12.5M | 4.28M | 7.70% | — |
| 5 | $11.9M | 450.6K | 7.32% | — | |
| 6 | $9.7M | 33.2K | 5.97% | — | |
| 7 | $9.1M | 970.0K | 5.60% | — | |
| 8 | $8.8M | 1.80M | 5.41% | — | |
| 9 | $6.3M | 425.0K | 3.88% | — | |
| 10 | $5.6M | 180.0K | 3.47% | — | |
| 11 | $5.6M | 62.5K | 3.43% | — | |
| 12 | $5M | 3.28M | 3.06% | — | |
| 13 | $4.8M | 764.2K | 2.96% | — | |
| 14 | $4.7M | 95.0K | 2.92% | — | |
| 15 | $4.6M | 55.0K | 2.83% | — | |
| 16 | $4.1M | 175.7K | 2.55% | — | |
| 17 | $2M | 135.0K | 1.25% | — | |
| 18 | $714K | 200.0K | 0.44% | — | |
| 19 | $538K | 65.0K | 0.33% | — |